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Objective: A meta-regression analysis was conducted to identify the most reliable treadmill protocol for the assessment of
patients with peripheral arterial disease (PAD).
Background: Treadmill testing is the main assessment method to evaluate walking ability in patients with PAD in clinical
studies. Reported treadmill protocols are continuous (C) and graded (G) protocols and outcome measurements are initial
claudication distance (ICD) and absolute claudication distance (ACD). Variety in protocols might hamper the ability to
compare results of different studies. Ideally, future studies should use a protocol with highest reliability.
Methods: We searched PubMed and EMBASE (until February 2008) and we hand searched the reference lists. Trials
assessing reliability of treadmill testing were identified. Inclusion criteria were the use of a C- or G-protocol, repetition
of this protocol, and a retrievable intraclass correlation coefficient (ICC). We identified eight studies in which 658
patients were included.
Results: For ICD, the estimated reliabilities of the C- and G-protocol (as assessed by the ICC) were 0.85 (95% confidence
interval [CI]: 0.82-0.88) and 0.83 (95% CI: 0.80-0.85), respectively, without dependency of the reliability on velocity or
grade. For ACD, the reliability was significantly better for the G-protocol (0.95, 95% CI: 0.94-0.96) than for the
C-protocol. Moreover, the reliability of the C-protocol was dependent on grade of the treadmill (0%, 10%, and 12%) with
a mean ICC of 0.76 (95% CI: 0.54-0.88), 0.89 (95% CI: 0.86-0.91), and 0.91 (95% CI 0.88-0.92), respectively.
Conclusion: Treadmill assessment has the highest reliability when using a G-protocol together with the ACD as the
primary outcome measure. ( J Vasc Surg 2009;50:322-9.)Characteristically, in patients with symptomatic periph-
eral arterial disease (PAD), pain starts during walking and
disappears in rest. Walking ability, as assessed by a treadmill
test, is usually the primary endpoint in clinical trials of
treatments for patients with PAD. Results of treadmill
testing are usually expressed as the initial claudication dis-
tance (ICD; the moment of the beginning of claudication
pain) and/or the absolute claudication distance (ACD; the
moment the test has to stop due to the maximal level of
bearable claudication pain). Although treadmill testing has
face validity for daily walking ability, there are several
limitations. While there is a relationship between daily
walking ability and objective criteria for the severity of
atherosclerotic lesions in the arteries of the legs (eg, the
angiographic extent of the disease1 and the subjective,
functional walking limitation for the patient2-4), there is
large variation. However, although the ability of treadmill
testing to diagnose PAD or to classify functional severity of
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322PAD is limited, the effects of treatment in properly de-
signed randomized controlled trials can be evaluated by
comparing treadmill results before and after treatment.
A wide range of treadmill protocols are used to assess
walking ability of patients with PAD. The traditional test
uses a constant speed and incline (continuous test or C-
test) during the entire assessment phase. Typically, the
speed is set to some value between 2 and 4 km/hour and
the gradient to either 0%, 10%, or 12%. However, due to a
wide range of walking distances in patients with PAD, it is
usually difficult to select one continuous protocol (C-
protocol) to assess all patients. Furthermore, the high initial
workload of the C-test may not be tolerated by patients
with severe PAD.
In the 1970s, a graded treadmill test (G-test) was
developed in cardiology to evaluate suspected ischemic
heart disease.5 Velocity of the treadmill is constant during
this test, but a gradual increase in slope of the treadmill
leads to a gradual increase in metabolic demand. Several
graded treadmill protocols (G-protocols) have also been
developed for PAD. Two frequently used G-protocols by
Hiatt et al6 and Gardner et al7 both use a constant speed of
3.2 km/hour. However, the Hiatt protocol starts with 0%
incline with 3.5% increase every 3 minutes6 while the
Gardner protocol starts with 0% and increments with 2%
every 2 minutes.7
C- and G-protocols with different speeds and inclines
of the treadmill result in varying workloads, hampering
adequate comparison of studies (Fig 1). Ideally, future
studies should use a treadmill protocol that has the highest
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pare the reliability of different treadmill protocols.
METHODS
Search strategy. A search of all articles related to the
reliability of treadmill testing in peripheral disease was
performed. To include all available evidence we searched
PubMed and EMBASE (until February 2008) for relevant
studies. The following search terms were used: ‘treadmill
test’, ‘exercise test’, ‘protocol’, ‘reproducibility’, ‘reliabil-
ity’, ‘peripheral arterial disease’, ‘intermittent claudication’,
and ‘peripheral occlusive disease’. In addition to the elec-
tronic search, the reference lists of selected articles were
reviewed and cross-references were examined. There was
no restriction on language of publication.
Selection of articles. Two authors (S.N. and L.K.)
selected eligible articles evaluating reliability of treadmill
testing by performing a repeated C- or G-test in patients
with PAD. Discrepancies were resolved by discussion, or if
this failed, by consulting W.V. and M.P. Studies were
excluded if the study population did not suffer from PAD
or if walking ability was not quantified by treadmill testing.
Eligible treadmill protocols were C-protocols, defined as
protocols with the treadmill set to a fixed speed and incline,
and G-protocols, defined as protocols with a fixed treadmill
velocity with an increase in inclination at specified time
intervals. Moreover, studies were excluded if the treadmill
protocol was not repeated within 3 weeks. We chose, for a
limited period of time, to diminish the effects of the natural
development of the disease. Finally, studies were excluded
Fig 1. Workloads for different treadmill protocols expressed as
kilocalories for a person of 70 kg. A, Different C-protocols.
B, G-protocols included in the analysis.if reliability was not presented as an intraclass correlationcoefficient (ICC) or the ICC could not be calculated from
the study’s data or data provided by the author(s) of the
study. Two reviewers (S.N. and M.P.) independently ap-
plied the inclusion criteria to select the relevant articles. In
case of any disagreement, the problem was resolved by
discussion.
Data extraction. Data of included studies were ex-
tracted by two reviewers (S.N. and W.V.). The following
information was sought from each study: number of pa-
tients, type of protocol (C- and/or G-protocol, velocity,
and incline), mean walking distances (ICD and ACD), and
the ICC for each walking distance measure.
Walking distances are defined as the ICD, correspond-
ing to the beginning of the claudication pain, and the ACD,
corresponding to the moment the test had to stop due to
the maximal level of bearable claudication pain. Written
data were preferred whenever possible. If written data were
not available, then walking distances with standard devia-
tions were read out of figures. Furthermore, if the standard
deviation was not provided, this was calculated from the
standard error of the mean and the number of patients.
Based on the available data, it was decided to obtain
ICC(1) values from the articles or through contact with the
authors. The ICC(1) is one out of several different intra-
class correlation coefficients that have been developed and
described in literature.8
In general, ICCs are measures of agreement or consis-
tency between measurements (or ratings). ICCs are partic-
ularly useful when more than two assessments have been
made on a group of subjects (as is frequently the case in
studies examining the reliability of treadmill protocols). For
example, while three different pair wise correlation coeffi-
cients could be calculated based on three assessments of the
ICD (or ACD) in a single group of patients, an ICC for the
same data would provide an overall measure of the test-
retest reliability of the three assessments. For example,
suppose the ICD values of 3 patients assessed at three
occasions are equal to 126m, 132m, and 136m at the first,
130m, 128m, and 136m at the second, and 126m, 134m,
and 134m at the third assessment. The three pair wise
correlations between the assessments are equal to 0.64,
0.92, and 0.28, yielding three rather different test-retest
correlations. On the other hand, the ICC(1) for these data
is equal to 0.73.
Moreover, the ICC(1) is a measure of absolute agree-
ment and, therefore, sensitive to changes in the average
walking distance over time. For example, suppose the ICD
values are equal to 126m, 132m, and 136m at the first,
134m, 140m, and 144m at the second, and 136m, 142m,
and 146m at the third assessment. Then all three pair wise
correlations are equal to 1, while the ICC(1) is equal to
0.36, suggesting a much lower absolute agreement in the
measurements over time.
In general, the ICC(1) is equal to the variability in the
walking distances between patients divided by the total
amount of variability in the data (which is equal to the
variability between patients plus the variability in the walk-
ing distance within patients). The ICC(1) value can be
imum
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patients included as the only factor in the model. Based on
the ANOVA table, we can calculate the ICC(1) with ICC
1  MSB  MSW ⁄ MSB  m  1MSW, where MSB is
the mean square corresponding to the patient factor, MSW
is the mean square error, and m denotes the number of
assessment occasions.
Data analysis. Since the distribution of ICC values is
quite skewed (especially when the values are close to 1), all
ICC(1) values were first converted with Fisher’s variance
stabilizing transformation for intraclass correlation coeffi-
cients,9 which is given by y  0.5ln1  m  1ICC
1 ⁄ 1  ICC1. The sampling variance of the trans-
formed values can then be approximated quite accurately
with v  m ⁄ 2m  1n  2, where n denotes the
number of patients included in the study. Since four studies
allowed the computation of multiple ICC(1) values from
the same sample, it was also necessary to calculate the
covariance between the dependent ICC(1) values. The
equation for the covariance is given by Donner and Zou.10
A fixed-effects meta-regression analysis was then performed
to evaluate the influence of velocity, grade, and type of
protocol (C- or G-protocol) on the reliability of treadmill
testing. The potential moderators were examined sepa-
rately and in combination. Estimated values and confidence
interval (CI) bounds based on the models were back-
transformed to estimated ICC(1) values with correspond-
ing CI bounds for easier interpretation. Tests for (residual)
heterogeneity were conducted with the Q-test. All tests
were conducted with   .05.
RESULTS
Identification of eligible studies. In total, the elec-
tronic andmanual literature search identified 43 potentially
eligible articles on title. After evaluation, articles presenting
Table I. Baseline characteristics of included studies
Study with year
Number of
patients
Treadmil
Velocity
(km/hour) Gr
Cachovan et al 1999 50 3.0
3.0
Degischer et al 2002 15 2.0
3.2
3.2
4.0
4.0
Chaudhry et al 1997 14 3.2
3.2
Gardner et al 1991 10 3.2
3.2
Gardner 1997 30 3.2
Labs et al 1999 330 3.2
Labs et al 1998 154 3.2
Zwierska et al 2004 55 3.2
C/G indicates continuous protocol or graded protocol; G1, graded protoco
graded protocol 2 with an increase in grade of 2% every 2 minutes to a maxan overview of the literature11,12 or letters to the editor13and studies not performing treadmill testing in PAD pa-
tients14,15 or not performing a treadmill test at all16 were
excluded. Furthermore, studies using non eligible treadmill
protocols individualized per patient were excluded.17-20
Twelve studies were excluded because of the lack of repe-
tition of an initial C- or G-test.3,18,21-30 In four studies, the
time between the treadmill tests exceeded our preset
limit.7,31-33 Finally, in nine studies, the ICC was not
available and it was not possible to determine the ICC from
the given data.6,34-41 Hence, eight studies could be in-
cluded. In total, these studies reported 29 different ICCs.
Study characteristics. The eight studies included a
total of 658 patients. To determine reliability, four studies
repeated one protocol.42-45 The other four studies com-
pared more treadmill protocols within the same group of
patients.46-49 Both C- and G-protocols were tested. The
majority used a velocity of 3.2 km/hour, but also 2, 3, and
4 km/hour were used. Within a period of 3 weeks, all tests
were repeated 2 or 3 times. Baseline characteristics of the
included studies are described in Table I.
Reliability of different protocols. In Table II, the
mean walking distances (ICD and ACD) are presented for
all included studies as well as the reported or calculated
ICC(1) values. The estimated reliabilities of the C- and
G-protocol for the ICD, as assessed by the ICC(1), were
0.85 (95% CI: 0.82-0.88) and 0.83 (95% CI: 0.80-0.85),
respectively. The difference in the estimated ICC(1) values
between the two protocols was not statistically significant
(z 1.40, P .16). For the ICD, there was no dependency
of the reliability on velocity (z  0.01, P  .99) or grade
(z 1.38, P .17). In fact, no heterogeneity was detected
within these data (Q  15.71, df  13, P  .27).
For the ACD, the reliability, as assessed by the ICC(1),
was significantly better (z  5.01, P  .001) for the
G-protocol (0.95, 95% CI: 0.94-0.96) than for the C-
ocol
Number of
assessments Time between assessments%) C/G
C 3 All assessments in 1 week
G1 3
C 2 All assessments in 3 weeks
C 2
C 2
C 2
C 2
C 2 2-7 days
G1 2
C 3 1 week
G2 3
G2 3 1 week
G2 3 1 week
C 2 On the same day
C 3 Short period of time
h an increase in grade of 3.5% every 3 minutes to a maximum of 17.5%; G2,
of 18%.l prot
ade (
12
12
0
12
0
12
10
12
12
12
l 1 witprotocol (0.90, 95% CI: 0.88-0.92). Furthermore, the
istance
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(z  1.34, P  .18), but did depend on the grade (z 
2.55, P .01) of the treadmill protocol, with an estimated
ICC(1) of 0.76 (95% CI: 0.54-0.88), 0.89 (95% CI: 0.86-
0.91), and 0.91 (95% CI: 0.88-0.92) at 0%, 10%, and 12%,
respectively. Although, the reliability of the C-protocol
with 12% grade came close to that of the G-protocol, a
linear contrast between the estimated ICC(1) of the C-
protocol with 12% grade and the ICC(1) of the G-protocol
was statistically significant (z  4.67, P  .001). After
accounting for the difference in the C- andG-protocols and
the influence of grade, some residual heterogeneity was still
present (Q  22.51, df  12, P  .03). Table III summa-
rizes these results. The ICCs for ICD and ACD for the C-
and G-protocol of each study are graphically represented in
forest plots (Fig 2). In addition, leaving out the largest
study of Labs et al44 from the analysis led to the same
conclusions as reported above.
DISCUSSION
The present results suggest that the reliability of tread-
Table II. Walking distances as measured during the first t
studies
Study
Treadmill protocol
C/G
Velocity
(km/hour) Grade % Mean (m
Cachovan et al 1999 C 3.0 12 87.8
G1 3.0 165.5
Degischer et al 2002 C 2.0 12 136
C 3.2 0 187
C 3.2 12 102
C 4.0 0 160
C 4.0 12 102
Chaudhry et al 1997 C 3.2 10
G1 3.2
Gardner et al 1991 C 3.2 12 74
G2 3.2 179
Gardner 1997 G2 3.2
Labs et al 1999 G2 3.2 467.3
Labs et al 1998 C 3.2 12 84.52
Zwierska et al 2004 C 3.2 12 75*
C/G indicates continuous protocol or graded protocol; G1, graded protoco
graded protocol 2 with an increase in grade of 2% every 2 minutes to a m
distance; ICC(1), intraclass correlation coefficient type 1. SD, standard dev
*Mean of all measurements.
Table III. Estimated reliability of the C- and G-protocol
Continuous protocol
Estimated ICC(1) (95% CI)
ICD 0.85 (0.82-0.88)
ACD 0.90 (0.88-0.92)
0% grade 0.76 (0.54-0.88)
10% grade 0.89 (0.86-0.91)
12% grade 0.91 (0.88-0.92)
ICC(1), intraclass correlation coefficient type 1; ICD, initial claudication dmill assessments is highest when the ACD is measured incombination with the use of a G-protocol. When a C-
protocol must be used for practical reasons (eg, due to the
unavailability of a treadmill which is automatically adjust-
able in gradient), a C-protocol should be used with a 12%
grade. The ACD should still be selected as the primary
outcome measure in that case. Furthermore, we did not
find a difference between three investigated G-protocols,
which corresponds to the apparently equal workloads of
these protocols (Fig 1, b).
Current guidelines. Treadmill testing is considered
an objective method for assessing therapy success and for
comparing the effectiveness of different treatments. How-
ever, European and North American guidelines from the
past decades provide different recommendations regarding
the use of treadmill testing in clinical trials. Heidrich et al50
stated in the “Guidelines for therapeutic studies in Fon-
taine’s stage II-IV peripheral arterial disease” from the
German Society of Angiology that the primary test out-
come should be the ICD assessed with a C-test (3 km/hour
12%). The Vascular Clinical Trialists advises to use a G-test
with a large dynamic range. The preferable primary test
ill test and reported or calculated ICC(1) from included
ACD
ICC(1) ICD ICC(1) ACDSD Mean (m) SD
60.3 149.2 120.0 0.880 0.910
122.1 262.3 177.4 0.870 0.910
61 250 109 0.792 0.843
121 405 219 0.817 0.614
46 204 116 0.713 0.855
75 315 114 0.828 0.835
37 167 80 0.833 0.952
0.680 0.930
0.840 0.980
35 176 70 0.484 0.715
82 376 168 0.600 0.883
237* 178* 0.950
345 939 652.6 0.820 0.952
65.28 145.77 86.89 0.870 0.910
71* 115* 93* 0.880 0.870
h an increase in grade of 3.5% every 3 minutes to a maximum of 17.5%; G2,
m of 18%; ICD, initial claudication distance; ACD, absolute claudication
rms of ICC(1) values
Graded protocol
P value for test
of the differenceEstimated ICC(1) (95% CI)
0.83 (0.80-0.85) .16
0.95 (0.94-0.96)  .001
; ACD, absolute claudication distance; CI, confidence interval.readm
ICD
)
l 1 wit
aximu
iation.in teoutcome (ICD or ACD) is not described. Although it is not
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outcome, it is described that the coefficient of variation of
the ACD is estimated lower than the ICD (12% vs 20%),
which implies that the ACD should be preferred. More
recent clinical trial guidelines in PAD recommendmeasure-
ment of the ACD by treadmill testing, which may be
Fig 2. a, Forest plot of the ICC(1) values for ICD. b, Forest plot
of the ICC(1) values for ACD.performed with a C-test (3.2 km/hour and 12%) or G-test(no advice), except for extreme walking distances when a
G-test should be performed.51 The American College of
Sports Medicine advises to perform exercise testing with a
graded treadmill protocol (at 3.2 km/hour with 2% in-
crease every 2 minutes or 3.5% increase every 3 minutes) or
a gradual ramp protocol, starting at low speed and without
incline and increasing continuously in speed and incline.
The ICD and ACD should be recorded.52
Our results would suggest that in terms of reliability,
the best measurement should be the ACD assessed by a
G-protocol as a first choice and the ACD of the C-protocol
as a second choice based on the estimated ICCs. Reliability
for the ICD, as well the C- as the G-protocol, although the
ICCs are still reasonably high, is lower than the estimated
reliability for the ACD. From the patient’s perspective, the
increase in ICD after treatment could be of more concern
than the increase of the ACD because it defines the range of
activities that can be performed without complaints. How-
ever, most patients will continue to walk after appearance of
the first signs of pain (ICD), few will walk until their
maximum pain threshold (ACD) is reached during the
course of daily activities.
Treadmill testing. Although treadmill testing is in-
deed the gold standard for the assessment of walking dis-
tances, there are several limitations. In clinical trials, there is
an external validity problem since patients with PAD can be
asymptomatic or have non-typical symptoms.53 This might
hamper the enrollment of patients with typical intermittent
claudication symptoms. Furthermore, there can be a pro-
nounced baseline variability in walking distance that can
differ between days. It is recommended that patients who
by history have a recognized potential for instability (eg,
recent phases of deterioration or improvement, or recent
surgical or peripheral vascular intervention) should be ex-
cluded. Testing for baseline stability in the run-in phase
should not be mandatory.51 Moreover, in daily practice
treadmill testing is impractical, it is time-consuming, re-
quires adequate equipment and personnel, and it is not
directly available for all physicians. A large discrepancy has
been reported between walking ability and claudication
walking distances as measured on a treadmill,2-4 implying
that treadmill assessments may not be representative of
daily life walking ability. Alternative more simple tests
include a 6-minute walking test,16,54 a shuttle walking-
test,16,45 a PADHOC device,22 and a global positioning
system (GPS) device.55 Furthermore, a simple question-
naire like the Walking Impairment Questionnaire (WIQ)
could be used in properly designed trials.56,57 A recent
study of McDermott et al58 indicated that functional per-
formance measures as the 6-minute walking test correlate
more closely to physical activity levels during daily life than
treadmill walking performance.
Methodologic points of attention. An adequate lit-
erature search was performed and eight studies analyzing
15 treadmill protocols in a total of 658 patients, could be
included. Although the study designs of nine other studies
met the inclusion criteria for this analysis, they could not be
included because of lack of ICC data. In these nine studies,
C, intr
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description of these studies is presented in Table IV. Even
though 9 out of 17 eligible studies were excluded, the
majority of the excluded studies presented results consis-
tent with this meta-analysis. Another limitation is that four
of the included studies in this analysis involved a rather
small number of patients.
Another subject of discussion is the type of ICC (abso-
lute agreement or consistency) and the type of statistical
model that is most sensible for this type of data. An ICC for
absolute agreement would only be equal to 1 if the ICD/
ACD values of the repeated measurements would be ex-
actly identical for each person. A constant difference for all
individuals between the repeated measurements reduces
the value of the ICC below unity. On the other hand, an
ICC for consistency would not be influenced by changes
that affect all individuals equally. Therefore, an increase in
walking distance, for example, due to a learning effect
would have no influence on the ICC for consistency, as
long as this increase is consistent for all patients.
Furthermore, there are various models that can be
assumed to describe the structure of this type of data.
Ideally, a fixed effect for time should be included in the
model, since the measurement occasions are not inter-
changeable. Therefore, either an ICC(A,1) or an ICC(C,1)
could be considered a more appropriate measure of the
reliability, either in terms of absolute agreement or in terms
of consistency.8 However, only the ICC(1), which is a
measure of absolute agreement not considered a potential
Table IV. Description of the excluded studies due to lack
Study with year
Number of
patients
Treadmill pro
Velocity
(km/hour)
Grad
(%)
Brass et al 2007 386 3.2
Clyne et al 1979 117 2 0
Cristol et al 1985 75 3 12
Harris et al 1987 25 2.4 0
Hiatt et al 1988 20 3.2
4.8
Johnston et al 1987 15 2.4 12
Laing et al 1986 50 4 10
Lindgärde et al 1996 154 3.2 12.3
Peräkylä et al 1998 10 3.2
3.2
3.2
0
12
C/G indicates continuous protocol or graded protocol; G1, graded protoco
graded protocol 2 with an increase in grade of 2% every 2 minutes to a maxim
ICD, initial claudication distance; ACD, absolute claudication distance; ICtime effect, was reported or could be computed for allstudies. If there are large changes in the mean ICD and
ACD values over time, then the ICC(1) will generally be
smaller than the corresponding ICC(A,1) value. Since the
mean ICD and ACD could be considered to be stable over
time due to the limited period of time between the tests,
the difference between these two types of ICC should be
relatively minor.
Finally, since some of the studies used multiple proto-
cols with the same individuals, we had to compute the
covariance between the resulting dependent ICC(1) values.
To use the equation for the covariance given by Donner
and Zou,10 we needed to know the correlation between the
ICD (and ACD) values across protocols. None of the
studies reported that information, so we estimated that
value at 0.7 and conducted sensitivity analyses (using values
between 0 and 0.9) to examine the robustness of the results
to this assumed value. The results from the sensitivity
analyses indicated that all of the conclusions are robust to
misspecification of this correlation.
Future implications. The results of this study would
suggest that many guidelines on clinical trials in patients
with PAD require updating concerning walking ability
assessment by treadmill testing. Ideally, there should be
one international preferable standard. The present analysis
suggests that a G-test protocol with absolute claudication
distance as the primary outcome measure is the test modal-
ity with highest reliability. Estimated reliabilities for the
C-protocol and the ICD were also reasonably high, indi-
cating that under certain circumstances these could also be
C(1) data
Main conclusion on treadmill testingC/G
G2 G-test quantifies ACD with high reproducibility and
stability over time.
C The ACD achieved was reproducible. Highly
significant delay of the ICD during the second
test.
C Overall reproducibility of the ACD was 10.8% 
8.6 with large individual variation.
C Significant increase in ICD and ACD on test 3
compared with test 1.
G1
G3
An accurate and reproducible estimation of ACD
could be achieved from either treadmill protocol.
C The ACD proved to be reproducible.
C The ICD and ACD may vary considerably from visit
to visit.
C Overall, the reproducibility of treadmill results was
high. Correlation coefficients for ICD and ACD
were 0.9 (exact ICC data were not given).
C
C
G2
Exercise testing appeared inaccurate. The G-test was
most reproducible and the C-test with 0% incline
least reproducible. ACD seemed to be more
reliable than ICD.
h an increase in grade of 3.5% every 3 minutes to a maximum of 17.5%; G2,
f 18%; G3, graded protocol 3 with increase in grade of 2.5% every 3 minutes.
aclass correlation coefficient.of IC
tocol
e
l 1 wit
um oan adequate test protocol and outcome measurement.
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studies, preferably guidelines for clinical trials on treatment
of patients with peripheral arterial disease should be
adapted and a uniform test protocol should be advised for
future studies.
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